Nutex Health Inc

Healthcare · Medical Care Facilities

214.30$ -1.4% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Nutex Health Inc (NUTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 211 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NUTX
Line item	Q3 11	Q4 11	Q1 16	Q2 16	Q3 16	Q1 17	Q2 17	Q3 17	Q1 18	Q2 18	Q3 18	Q1 19	Q2 19	Q3 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	0.6	0.7	0.4	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.4	0.4	106	2.0	63	118	63	79	58	28	54	56	59	63	70	67	76	79	258	212	244	268	152	216	211	847
Cost of Revenue	0.4	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.4	0.1	0.3	0.4	0.2	–	1.6	34	42	41	43	51	52	53	51	49	51	56	57	54	57	116	93	119	113	106	125	69	413
Gross Profit	0.2	0.3	0.4	0.6	0.8	0.0	-0.3	0.0	-0.2	-0.2	-0.2	0.0	0.1	0.1	0.1	0.0	0.1	–	0.4	29	76	22	36	6.6	-24	0.5	4.8	9.6	12	13	10	23	22	142	118	125	155	46	92	141	434
Research & Development	–	–	–	–	–	–	–	–	–	–	–	0.2	0.3	–	0.1	0.3	0.1	–	0.1	0.1	0.1	0.2	0.1	–	–	0.1	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	0.5	0.5	–	–	–	–	1.2	0.7	0.2	0.3	0.2	0.2	0.2	0.2	3.1	1.3	0.7	41	4.4	1.5	1.5	0.4	6.6	4.1	6.8	6.3	9.1	10	7.8	9.1	8.7	11	12	27	10	91	11	18	14	20	63
Total Operating Expenses	0.5	0.5	0.6	0.6	0.5	0.2	0.9	0.7	0.2	0.3	0.2	1.0	1.6	0.4	1.1	1.7	0.8	43	4.6	1.5	1.5	6.7	6.6	8.0	405	-4.0	9.3	10	13	39	8.7	17	12	27	46	210	25	15	10	20	70
Operating Income	-0.2	-0.2	-0.2	0.0	0.3	-0.2	-1.2	2.5	-2.4	-2.5	-2.3	-84	-84	-84	-0.9	-1.7	-0.6	63	-4.1	28	74	16	29	-1.4	-429	4.6	-4.4	-0.4	-0.8	-26	1.4	5.3	9.7	114	72	34	130	31	81	122	364
Interest Expense	–	–	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.3	1.5	1.3	1.9	1.9	4.4	3.4	2.9	3.1	4.8	4.1	4.2	4.4	5.1	5.4	5.1	6.1	5.7	5.5	5.0	4.7	4.7	20
Pre-Tax Income	-0.2	-0.2	-0.2	-0.1	0.2	-0.2	-1.6	-0.3	-4.3	-4.5	-4.3	-79	-79	-79	-1.0	0.2	1.8	61	-4.5	30	75	13	25	-4.3	-431	1.5	-7.8	-5.1	-4.9	-31	-0.2	3.9	-2.6	109	63	24	124	26	77	117	343
Income Tax Expense	-0.1	-0.1	–	–	–	–	–	–	0.1	–	–	0.0	0.0	0.0	0.0	-0.1	-0.1	–	0.0	0.5	0.5	-0.1	0.2	20	-8.5	1.8	-0.9	-0.8	-0.3	-3.0	0.4	0.9	4.6	8.6	19	–	27	9.3	14	21	71
Net Income	-0.2	-0.2	-0.2	-0.1	0.2	-0.2	-1.6	6.3	-0.6	-0.7	-0.6	-1.0	-1.6	-0.9	-1.3	0.2	1.8	40	-4.4	27	54	14	21	-19	-412	-4.4	-5.1	-3.5	-5.5	-32	-0.4	-0.4	-8.8	62	15	-18	55	12	47	66	180
EBITDA	-0.2	0.0	-0.2	0.0	0.3	-0.2	-1.3	-0.7	-0.6	-0.3	0.6	-0.4	-1.4	-0.9	-0.8	0.6	1.8	43	-4.1	36	78	20	29	3.2	-424	7.6	-0.7	3.9	1.1	-22	8.5	13	7.8	119	74	–	134	36	87	127	384

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings